These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 31041232)

  • 1. A pharmacoeconomic analysis to compare cost-effectiveness of metformin plus teneligliptin with metformin plus glimepiride in patients of type-2 diabetes mellitus.
    Tandon T; Dubey AK; Srivastava S; Manocha S; Arora E; Hasan N
    J Family Med Prim Care; 2019 Mar; 8(3):955-959. PubMed ID: 31041232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Teneligliptin Real-World Effectiveness Assessment in Patients with Type 2 Diabetes Mellitus in India: A Retrospective Analysis (TREAT-INDIA 2).
    Ghosh S; Tiwaskar M; Chawla R; Jaggi S; Asirvatham A; Panikar V
    Diabetes Ther; 2020 Oct; 11(10):2257-2268. PubMed ID: 32779100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness and Safety of Hydroxychloroquine compared to Teneligliptin in uncontrolled T2DM patients as add-on Therapy.
    Kumar A; Prakash AS
    J ASEAN Fed Endocr Soc; 2019; 34(1):87-91. PubMed ID: 33442141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin.
    Hermansen K; Kipnes M; Luo E; Fanurik D; Khatami H; Stein P;
    Diabetes Obes Metab; 2007 Sep; 9(5):733-45. PubMed ID: 17593236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Teneligliptin real-world efficacy assessment of type 2 diabetes mellitus patients in India (TREAT-INDIA study).
    Ghosh S; Trivedi S; Sanyal D; Modi KD; Kharb S
    Diabetes Metab Syndr Obes; 2016; 9():347-353. PubMed ID: 27877058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Safety and Efficacy of Glimepiride-Metformin and Vildagliptin- Metformin Treatment in Newly Diagnosed Type 2 Diabetic Patients.
    Kumar S
    Indian J Endocrinol Metab; 2021; 25(4):326-331. PubMed ID: 35136740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Evaluation of Safety and Efficacy of Glimepiride and Sitagliptin in Combination with Metformin in Patients with Type 2 Diabetes Mellitus: Indian Multicentric Randomized Trial - START Study.
    Devarajan TV; Venkataraman S; Kandasamy N; Oomman A; Boorugu HK; Karuppiah SKP; Balat D
    Indian J Endocrinol Metab; 2017; 21(5):745-750. PubMed ID: 28989886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Teneligliptin in management of type 2 diabetes mellitus.
    Sharma SK; Panneerselvam A; Singh KP; Parmar G; Gadge P; Swami OC
    Diabetes Metab Syndr Obes; 2016; 9():251-60. PubMed ID: 27574456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term efficacy and safety of repaglinide versus glimepiride as augmentation of metformin in treating patients with type 2 diabetes mellitus.
    Xie J; Li N; Jiang X; Chai L; Chen JJ; Deng W
    Diabetes Metab Syndr Obes; 2019; 12():519-526. PubMed ID: 31114280
    [No Abstract]   [Full Text] [Related]  

  • 11. Combination Therapy with a Dipeptidyl Peptidase-4 Inhibitor, Sulfonylurea, and Metformin Markedly Improves HbA1c Levels in Japanese Patients with Type 2 Diabetes Mellitus.
    Hirao K; Maeda H; Shirabe S; Yamamoto R; Hirao T; Hirao S; Yamauchi M; Arai K
    Jpn Clin Med; 2012; 3():1-7. PubMed ID: 23946679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Safety of Teneligliptin in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Li X; Huang X; Bai C; Qin D; Cao S; Mei Q; Ye Y; Wu J
    Front Pharmacol; 2018; 9():449. PubMed ID: 29780322
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy and Safety of Switching to Teneligliptin in Patients with Type 2 Diabetes Inadequately Controlled with Dipeptidyl Peptidase-4 Inhibitors: 52-Week Results from a Prospective Observational Study.
    Kim HJ; Kim YS; Lee CB; Choi MG; Chang HJ; Kim SK; Yu JM; Kim TH; Lee JH; Ahn KJ; Min KW; Kyung EJ; Kim YK; Lee KW
    Diabetes Ther; 2021 Nov; 12(11):2907-2920. PubMed ID: 34536208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of vildagliptin-metformin and glimepiride-metformin treatments in type 2 diabetic patients.
    Jeon HJ; Oh TK
    Diabetes Metab J; 2011 Oct; 35(5):529-35. PubMed ID: 22111045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the Safety and Efficacy of Teneligliptin at a Higher Dose in Indian Type 2 Diabetes Patients: A Retrospective Analysis.
    Mitra A; Ray S
    Cureus; 2020 Jan; 12(1):e6812. PubMed ID: 32140368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vildagliptin compared to glimepiride on post-prandial lipemia and on insulin resistance in type 2 diabetic patients.
    Derosa G; Bonaventura A; Bianchi L; Romano D; Fogari E; D'Angelo A; Maffioli P
    Metabolism; 2014 Jul; 63(7):957-67. PubMed ID: 24874591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety profile of glimepiride in Mexican American Patients with type 2 diabetes mellitus: a randomized, placebo-controlled study.
    Luis Bautista J; Bugos C; Dirnberger G; Atherton T
    Clin Ther; 2003 Jan; 25(1):194-209. PubMed ID: 12637120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Safety of Teneligliptin in Indian Patients with Inadequately Controlled Type 2 Diabetes Mellitus: A Randomized, Double-blind Study.
    Agarwal P; Jindal C; Sapakal V
    Indian J Endocrinol Metab; 2018; 22(1):41-46. PubMed ID: 29535935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Teneligliptin in Early Diabetic Kidney Disease: An Observation in Asian Indian Patients with Type 2 Diabetes Mellitus in Real-Life Scenario.
    Shah K
    J Clin Diagn Res; 2017 Jun; 11(6):OC22-OC25. PubMed ID: 28764219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy and safety of glimepiride plus metformin in a single presentation, as combined therapy, in patients with type 2 diabetes mellitus and secondary failure to glibenclamide, as monotherapy].
    González-Ortiz M; Martínez-Abundis E;
    Rev Invest Clin; 2004; 56(3):327-33. PubMed ID: 15612515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.